Pediatric Neurology 1999-04-01

Midazolam and pentobarbital for refractory status epilepticus.

G L Holmes, J J Riviello

Index: Pediatr. Neurol. 20(4) , 259-64, (1999)

Full Text: HTML

Abstract

Status epilepticus, a serious, life-threatening emergency characterized by prolonged seizure activity, occurs most commonly in pediatric patients. Although initial therapies with agents such as diazepam, phenytoin, or phenobarbital generally terminate seizure activity within 30-60 minutes, patients with refractory status epilepticus (RSE) lasting longer require additional intervention. High-dose pentobarbital has been the most commonly prescribed agent for the management of RSE in children; however, midazolam has emerged as a new treatment option. This review compares the use of midazolam with pentobarbital in published reports of pediatric RSE. Both drugs effectively terminated refractory seizure activity, although pentobarbital use was complicated by hypotension, delayed recovery, pneumonia, and other adverse effects. Midazolam use was effective and well tolerated, affirming its value in pediatric RSE management.

Related Compounds

  • Pentobarbital

Related Articles:

The slow death of lethal injection.

2014-04-01

[BMJ 348 , g2670, (2014)]

Ascorbic acid reverses the prolonged anesthetic action of pentobarbital in Akr1a-knockout mice.

2014-01-24

[Life Sci. 95(1) , 1-8, (2014)]

Optimized administration regimen of lopinavir for a myocardial ischaemia reperfusion study in Sprague-Dawley rats.

2013-04-01

[Lab. Anim. 47(2) , 122-6, (2013)]

Hemodiafiltration in pentobarbital poisoning.

1996-03-01

[Ren. Fail. 18(2) , 299-303, (1996)]

Impairment of an electroconvulsive stimulus on reconsolidation of memories established by conditioning.

2013-02-28

[Chin. J. Physiol. 56(1) , 44-51, (2013)]

More Articles...